{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"DAREONTM-7: A Phase I, open-label, dose escalation and expansion trial to investigate safety and tolerability of BI 764532 intravenous infusions in combination with standard of care (platinum and etoposide) in first-line treatment of patients with neuroendocrine carcinomas (NEC)","item":"https:\/\/www.regionalcancercare.org\/trials\/dareontm-7-a-phase-i-open-label-dose-escalation-and-expansion-trial-to-investigate-safety-and-tolerability-of-bi-764532-intravenous-infusions-in-combination-with-standard-of-care-platinum-and-etop\/#breadcrumbitem"}]}